Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec 15;200(12):1466-1471.
doi: 10.1164/rccm.201910-1999PP.

A Perspective: Division of Lung Diseases at Fifty

Gail G Weinmann  1 , Thomas L Croxton  1 , Neil R Aggarwal  1 , Michael J Twery  1 , James P Kiley  1 ; NHLBI Division of Lung Diseases staff
Collaborators, Affiliations

A Perspective: Division of Lung Diseases at Fifty

Gail G Weinmann et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Graphical history of NHLBI’s Division of Lung Diseases (DLD). (A) Time trend of DLD funding of extramural research for the period 1969–2018. (B) Selected representative initiatives developed and funded by DLD that reflect the evolving nature of pulmonary research over the past five decades. Initially, DLD focused on establishing a robust research community at the cutting edge of science by steering investigators from physiology to more basic and cellular work and encouraging research training (not shown). Early initiatives focused on identifying lung cells and basic mechanisms, gradually over time focusing on particular diseases and conditions. In the second era, starting in the early 1990s, DLD addressed the paucity of investigator-initiated clinical trials in lung disease by releasing initiatives for clinical research networks. These clinical trial results revealed the heterogeneity of responses to treatment and led to the third and current era with the development of programs defining phenotype–genotype relationships as a first step toward identifying targets for novel and personalized treatments. Full names of the programs identified by acronyms in the figure are given in the appendix in the online supplement.
See this image and copyright information in PMC

References

    1. Hurd SS, Lenfant C. NHLBI: fifty years of achievement in pulmonary biology and medicine. Am J Respir Crit Care Med. 1998;157:S168–S171. - PubMed
    1. National Heart, Blood Vessel, Lung and Blood Program. Report of the Lung Diseases Panel. DHEW Publication No. (NIH) 73-519. Washington, DC: U.S. Government Printing Office; 1973.
    1. Ardini-Poleske ME, Clark RF, Ansong C, Carson JP, Corley RA, Deutsch GH, et al. LungMAP Consortium. LungMAP: the molecular atlas of lung development program. Am J Physiol Lung Cell Mol Physiol. 2017;313:L733–L740. - PMC - PubMed
    1. Avery ME, Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. AMA J Dis Child. 1959;97:517–523. - PubMed
    1. National Heart, Lung and Blood Institute. Respiratory Diseases Task Force. report on problems, research approaches, needs. DHEW Publication No. 73-432. Washington, DC: U.S. Government Printing Office; 1972.